Refereed journal article or data article (A1)

Quantification of [F-18]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients




List of AuthorsGolla SSV, Boellaard R, Oikonen V, Hoffmann A, van Berckel BNM, Windhorst AD, Virta J, Haaparanta-Solin M, Luoto P, Savisto N, Solin O, Valencia R, Thiele A, Eriksson J, Schuit RC, Lammertsma AA, Rinne JO

PublisherNATURE PUBLISHING GROUP

Publication year2015

JournalJournal of Cerebral Blood Flow and Metabolism

Journal name in sourceJOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Journal acronymJ CEREBR BLOOD F MET

Volume number35

Issue number5

Start page766

End page772

Number of pages7

ISSN0271-678X

eISSN1559-7016

DOIhttp://dx.doi.org/10.1038/jcbfm.2014.261


Abstract

Fluorine-18 labelled N, N-diethyl-2-(2-[4-(2-fluoroethoxy)phenyl]-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-yl) acetamide ([F-18] DPA-714) binds to the 18-kDa translocator protein (TSPO) with high affinity. The aim of this initial methodological study was to develop a plasma input tracer kinetic model for quantification of [F-18] DPA-714 binding in healthy subjects and Alzheimer's disease (AD) patients, and to provide a preliminary assessment whether there is a disease-related signal. Ten AD patients and six healthy subjects underwent a dynamic positron emission tomography (PET) study along with arterial sampling and a scan protocol of 150 minutes after administration of 250 +/- 10 MBq [F-18] DPA-714. The model that provided the best fits to tissue time activity curves (TACs) was selected based on Akaike Information Criterion and F-test. The reversible two tissue compartment plasma input model with blood volume parameter was the preferred model for quantification of [F-18] DPA-714 kinetics, irrespective of scan duration, volume of interest, and underlying volume of distribution (V-T). Simplified reference tissue model (SRTM)-derived binding potential (BPND) using cerebellar gray matter as reference tissue correlated well with plasma input-based distribution volume ratio (DVR). These data suggest that [F-18] DPA-714 cannot be used for separating individual AD patients from heathy subjects, but further studies including TSPO binding status are needed to substantiate these findings.



Last updated on 2021-24-06 at 10:56